NCT02529605View on ClinicalTrials.gov

Relative Bioavailability of Two Different Milk Thistle Formulations

NACompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

June 30, 2017

Study Completion Date

June 30, 2017

Conditions
Healthy
Interventions
DIETARY_SUPPLEMENT

Product B® IsaGenesis®

This will be a crossover comparison of a one time dose of the liquid-gel formulation contained in 2 capsules; 1280 mg/capsule.

DIETARY_SUPPLEMENT

IsaGenesis®

This will be a crossover comparison of a one time dose of the dried powder extract contained in 2 capsules; 1070 mg /capsule.

Trial Locations (1)

32610

Uf Ctsi Crc, Gainesville

Sponsors
All Listed Sponsors
collaborator

Isagenix International LLC

INDUSTRY

lead

University of Florida

OTHER